Pfizer CEO criticizes US drug price negotiation tactics.

Pfizer CEO Albert Bourla criticized the US government's plan to negotiate drug prices for its Medicare health program, calling it "negotiation with a gun to your head" and expects drugmakers to sue to halt the process. The law aims to save $25 billion through price negotiations by 2031 for Americans who pay more for medicines than any other country. The pharmaceutical industry says the law will result in a loss of profits that will force drugmakers to pull back on developing groundbreaking new treatments.